SEP 25, 2020 7:00 AM PDT

Ray of Hope: Rare Cancer Biomarker Discovered

WRITTEN BY: Tara Fernandez

Biliary tract cancer, or BTC, isn’t as talked about as breast or prostate cancers, probably because its incidence is much rarer. BTCs are a group of gastrointestinal tumors including gallbladder cancers whose prevalence is increasing in South America and Asia. In Western countries, only around 1.6 in every 100,000 get diagnosed with the disease, but when they do, the mortality rate is staggeringly high: most patients die within 1 year of starting chemo.

A team of Danish researchers has identified a silver lining for BTC patients — a biomarker that can serve as a barometer for how aggressive the cancer is.

Speaking on the significance of the discovery, Jesper Andersen, one of the scientists leading the study said: "We have found a biomarker that reliably predicts how aggressively a patient’s disease will evolve, which in the future could help doctors in the hospitals make the right decisions about chemotherapy for the benefit of each BTC patient." 

The new metric involves quantifying the levels of two inflammatory proteins, interleukin-6 (IL-6) and YKL-40 during the patient’s journey from the initial diagnosis to the initiation of chemotherapy and beyond. Despite being incredibly rare, the researchers managed to obtain over 1500 blood samples from 452 patients diagnosed with advanced BTC. A study of this magnitude is unprecedented in the field and may prove to be transformative in improving BTC patient outcomes in the long run.

The team also uncovered another utility for targeting IL-6 beyond the scope of a diagnostic. In mouse models of BTC, blocking the cellular signaling pathways controlled by IL-6 dramatically improved the reduction in tumor size following chemotherapy.

 

Source: MedicalXpress, Clinical Cancer Research.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
OCT 13, 2020
Cardiology
A Kidney Toxin Could Act as a Biomarker for Cardiovascular Risk
OCT 13, 2020
A Kidney Toxin Could Act as a Biomarker for Cardiovascular Risk
Biomarkers have taken the diagnostic field by storm over the past decade. The search for stable, easy to access indicato ...
NOV 09, 2020
Genetics & Genomics
Potential Problems with Liquid Biopsies
NOV 09, 2020
Potential Problems with Liquid Biopsies
Liquid biopsies are tests that look for biomarkers in the blood, which can help inform the treatment of cancer. The tool ...
NOV 24, 2020
Cancer
Using Restfulness as a Metric for Measuring Sleep Quality and Cardiovascular Risk
NOV 24, 2020
Using Restfulness as a Metric for Measuring Sleep Quality and Cardiovascular Risk
Did you know sleeping is great? Apparently, getting a full eight hours every night can make you look fabulous and solve ...
DEC 19, 2020
Clinical & Molecular DX
Urine Tests Sets Parents' Minds at Ease in Minutes After a Miscarriage Threat
DEC 19, 2020
Urine Tests Sets Parents' Minds at Ease in Minutes After a Miscarriage Threat
Researchers have developed a chip-based test that can determine pregnancy outcomes after the signs of a possible miscarr ...
DEC 26, 2020
Clinical & Molecular DX
Navigating the Genomic Landscape of Cancer in Asians
DEC 26, 2020
Navigating the Genomic Landscape of Cancer in Asians
Precision medicine — a clinical paradigm that tailors treatments specifically to patients based on their genetic a ...
JAN 19, 2021
Clinical & Molecular DX
Fathers' Sperm Linked to Autism in Offspring
JAN 19, 2021
Fathers' Sperm Linked to Autism in Offspring
Researchers at Washington State University have uncovered a genetic link between fathers and children with autism spectr ...
Loading Comments...